US 12,357,778 B2
Mobile inhaler and a container for using therewith
Abraham Marmur, Haifa (IL); Philippe Lacour-Gayet, Bel Ombre (MU); Julien Lacour-Gayet, Lacroix-sur-Lutry (CH); Dror Nedivi, Petach Tikva (IL); Francesco Guidetti, Chernex (CH); and Zeev Shpiro, Tel-Aviv (IL)
Assigned to SKYX IP HOLDINGS I LLC, New York, NY (US)
Filed by SkyX IP Holdings I LLC, New York, NY (US)
Filed on Aug. 19, 2021, as Appl. No. 17/407,061.
Application 17/407,061 is a continuation of application No. 15/770,735, abandoned, previously published as PCT/IL2017/050402, filed on Apr. 3, 2017.
Claims priority of application No. 16163666 (EP), filed on Apr. 4, 2016; application No. 16176635 (EP), filed on Jun. 28, 2016; application No. 16187618 (EP), filed on Sep. 7, 2016; and application No. 17155046 (EP), filed on Feb. 7, 2017.
Prior Publication US 2022/0040423 A1, Feb. 10, 2022
Int. Cl. A61M 15/06 (2006.01); A24F 40/05 (2020.01); A24F 40/30 (2020.01); A24F 40/42 (2020.01); A24F 40/44 (2020.01); A24F 40/51 (2020.01); A61M 11/00 (2006.01); A61M 11/04 (2006.01); A61M 15/00 (2006.01); A24F 40/10 (2020.01); A24F 40/49 (2020.01); A61M 16/00 (2006.01); A61M 16/10 (2006.01)
CPC A61M 15/06 (2013.01) [A24F 40/05 (2020.01); A24F 40/30 (2020.01); A24F 40/42 (2020.01); A24F 40/44 (2020.01); A24F 40/51 (2020.01); A61M 11/001 (2014.02); A61M 11/005 (2013.01); A61M 11/007 (2014.02); A61M 11/042 (2014.02); A61M 15/0003 (2014.02); A61M 15/0021 (2014.02); A61M 15/0085 (2013.01); A24F 40/10 (2020.01); A24F 40/49 (2020.01); A61M 15/009 (2013.01); A61M 2016/0024 (2013.01); A61M 2016/0027 (2013.01); A61M 16/1085 (2014.02); A61M 2202/0488 (2013.01); A61M 2205/123 (2013.01); A61M 2205/276 (2013.01); A61M 2205/3576 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/3592 (2013.01); A61M 2205/50 (2013.01); A61M 2205/581 (2013.01); A61M 2205/583 (2013.01); A61M 2205/60 (2013.01); A61M 2205/6018 (2013.01); A61M 2205/6072 (2013.01); A61M 2205/8206 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A mobile inhaler device, comprising:
a mouthpiece comprising at least one inhaling opening;
a body element connected to the mouthpiece and comprising a housing for holding a DC power source;
an enclosure holding a container that comprises a liquid in a cavity, wherein the container comprises a wick arranged in the cavity in contact with the liquid;
a power conversion unit comprising an inverter operative to convert a DC voltage provided by a DC power source, into a higher AC voltage;
a nebulizer comprising an ultrasonic vibrator and a mesh, the mesh having a disc shape and comprising a central, dome-shaped circular region having a convex side arranged to extend towards the at least one inhaling opening, the dome-shaped circular region comprising a plurality of openings, wherein the mesh is configured to be in contact with the wick, thereby preventing direct contact between the mesh and the liquid, wherein said ultrasonic vibrator is configured to vibrate the mesh and be activated by said AC voltage, and wherein the ultrasonic vibrator is an annular piezo-electric vibration generator, and wherein the mesh is directly attached to a lower side of the annular piezo-electric vibration generator and the dome-shaped circular region is aligned with a central hole of the vibration generator, and wherein said nebulizer is adapted to enable converting at least part of the liquid into aerosol droplets, and wherein the aerosol droplets are capable of being directly inhaled from said mouthpiece; and
wherein the enclosure is adapted to enable holding the liquid, and characterized in that the enclosure provides a connection to enable fluid transfer for said enclosure to the nebulizer, wherein:
the wick forms a second cavity and a support structure is arranged in the second cavity for supporting the wick; and
the arrangement of the wick and the support structure enables fluid transfer from the enclosure to the nebulizer irrespective of a spatial angle at which the mobile inhaler device is being held.